Sign In

Sandra Sanchez-Oldenhage

Strategist & results driven life sciences Sr. Executive. Operational & international experience in mature, start-up & turnaround/re-structuring ops leading to profitable growth. LATAM expert. Independent Board Member

Professional Background

Sandra Sanchez-Oldenhage is a seasoned Life Sciences executive with over 34 years of experience in leading operations within the dynamic realms of biotechnology, specialty care, and pharmaceuticals. Her impressive career spans multiple geographical regions—including Canada, Latin America, and select emerging markets in Asia and Africa—where she has successfully managed substantial revenue streams exceeding $750 million USD and a large workforce of over 1,500 individuals. Throughout her career, Sandra has demonstrated her exceptional capability in managing start-ups, revitalizing turn-around operations, and overseeing mature business segments.

With broad expertise in various industry segments such as rare diseases, vaccines, generics, biosimilars, and over-the-counter (OTC) products, Sandra has a proven track record of breaking into new markets through strategic alliances and collaborations. Her roles have involved general management, business development, government affairs, public policy, and market access—making her a leading voice in the industry.

Education and Achievements

Sandra’s academic credentials are equally impressive, having completed several prestigious programs. She graduated from the Post Graduate Global Executive Leadership Development Program in Business Administration, Management, and Operations at Harvard University's Kennedy School of Government and Cambridge’s Judge Institute of Management. Additionally, she completed the Executive Leadership Development Program at Harvard Business School and the Executive “On the Board” Program at The George Washington University - School of Business. Furthermore, Sandra earned her MBA from the Instituto Tecnológico y de Estudios Superiores de Monterrey, further solidifying her expertise in business administration.

As a bilingual and bicultural professional fluent in both English and Spanish, Sandra has utilized her rich cultural background to foster diversity within her teams, ensuring innovation and creativity remain at the forefront of her operational strategies. This commitment to embracing diversity has proven to be a significant competitive advantage in her distinguished career.

Notable Achievements

Sandra’s career is highlighted by numerous key positions in renowned companies within the pharmaceutical and biotechnology sectors. She currently holds the position of Regional General Manager for the NoLA Region and LATAM at Novartis, where she continues to influence significant strategic initiatives that drive growth and efficiency. Notably, she served as President and CEO of PharmAdvice, where her leadership played a crucial role in navigating complex market challenges.

Her previous positions include a notable tenure at Pfizer as Regional Executive Director for Latin America, where she successfully led numerous projects that prioritized market access and enhanced product visibility. As a former General Manager at Biogen and Amgen, Sandra has consistently directed business operations towards achieving impressive revenue targets and operational excellence.

Moreover, Sandra’s governance capabilities have been recognized through her roles as Executive Board Member at SOHIN - Soluciones Hospitalarias Integrales, and Independent Board Member at Fénix Holding. This extensive board experience underscores her deep understanding of both profit and non-profit organizations and her commitment to responsible leadership in all endeavors.

In addition to her operational and strategic accomplishments, Sandra has a strong focus on talent development. Her efforts include recruiting, retaining, and mentoring high-performing individuals, ensuring her teams are equipped with the skills and expertise necessary for future challenges. This commitment to cultivating future leaders reflects her understanding that the true strength of an organization lies within its people.

Conclusion

Sandra Sanchez-Oldenhage’s blend of operational excellence, strategic foresight, and governance expertise truly sets her apart as a leader in the Life Sciences sector. Her career demonstrates a relentless pursuit of growth, with a keen eye for spotting untapped markets and business opportunities both regionally and globally. As she continues to innovate within her field, Sandra remains a beacon of integrity, discipline, and tenacity. Her ongoing dedication to fostering diversity and empowering her teams reinforces her role as an influential expert, positioning her as a key player in shaping the future of the Life Sciences industry.

Related Questions

How did Sandra Sanchez-Oldenhage develop her expertise in breaking into new markets within the pharmaceutical sector?
What strategies has Sandra Sanchez-Oldenhage implemented to foster diversity and empowerment within her teams?
In what ways has Sandra Sanchez-Oldenhage's bicultural background influenced her leadership style and decision-making processes?
What are some of the key challenges Sandra Sanchez-Oldenhage has faced in managing international teams across diverse markets?
How has Sandra Sanchez-Oldenhage contributed to the development of lucrative partnerships in the Life Sciences industry?
Sandra Sanchez-Oldenhage
Add to my network

Location

Mexico City Metropolitan Area